During the past decade, Sutter Institute for Medical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 14 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Institute for Medical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc." with 2 trials sponsored, "Cyberonics, Inc." with 2 trials sponsored and "NewLink Genetics Corporation" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Institute for Medical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Institute for Medical Research" are "Brain Cancer" (2 trials), "Breast Cancer" (2 trials), "Class IV Angina" (2 trials), "Epilepsy" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Sutter Institute for Medical Research" in a lesser frequency.

Most popular intervention types in "Sutter Institute for Medical Research" are "Drug" (16 trials), "Device" (6 trials), "Other" (4 trials), "Biological" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Gemcitabine" (2 trials), "5-FU Chemoradiation" (1 trials), "5FU Chemoradiation" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Institute for Medical Research" are 30 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sutter Institute for Medical Research". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sutter Institute for Medical Research, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Institute for Medical Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Sutter Institute for Medical Research has several departments that took part in Clinical trials: "Dorothy L & James E Frank Diabetes Research Institute" - 4 trials, "Diabetes Research Institute of Mills Peninsula" - 3 trials